ghk-cu fda approved - COA-Tested, 99%+ Pure ghk cu peptide fda approved

Key Takeaways BPC-157 is a Promising Peptide for Lyme Disease: Renowned for its regenerative and anti-inflammatory properties, BPC-157 offers potential benefits for those battling Lyme disease and co-infections by promoting tissue repair, reducing inflammation, and supporting immune function

Products are supplied with lot-coded identification and tamper-evident packaging

Skin changes Itchy skin or rash near the injection In rare cases, hives may appear Mild flushing or warmth in the cheeks 4

This is the pre-blended format, a single lyophilised vial co-formulated with BPC-157 5mg and TB-500 5mg, 10mg of total peptide under batch UKPL-855